Production flexibility is key for pharma

The global pharmaceutical manufacturing market is expected to be worth almost a trillion US dollars by 2028. This is a rapidly growing sector driven by a global population that is constantly on the rise and at the same time aging in many more developed parts of the world. As more individuals seek medications to improve their quality of life and wellbeing, the pharmaceutical industry is responding with increasingly personalised treatments, made possible by continued medical advances.

Production floor worker in a pharmaceutical manufacturing plant

As a result, the pharma industry needs to make more frequent product changeovers, with final production often postponed to a time closer to the moment of use. And, as the coronavirus pandemic has shown, sometimes there’s a need to ramp up production with little warning. To manage these diverse requirements, pharmaceutical manufacturers globally are shifting to more flexible and modular processing and packaging equipment.

Reliable supply

With more individualised treatments and the likelihood of more pandemics in the future, there will be no stock to fall back on if production is delayed due to equipment servicing or malfunction. Downtime for maintenance and upgrades must therefore be tightly scheduled, and the supply of spare parts must be completely reliable. MAG45 can assure the availability of all the necessary parts, components, and tools.

Warehouse worker using a bar code scanner

Scaling for the future

MAG45’s operating procedures are designed to support the sort of scalability that pharmaceutical manufacturers need. With production often located in multiple countries, alternative supply is assured including country-appropriate packaging, labelling and documentation.

We are also committed to automating our operations and processes. We see a more advanced warehouse and supply chain design in the future, where robotic systems become increasingly important. This will help to automate time-consuming manual tasks such as lineside stock replenishment, which can involve ‘walking’ several kilometres a day in large production facilities. In the end, through Artificial Intelligence, machine learning, and the Internet of Things, the promise of Industry 4.0 is fast becoming a reality.

The pharmaceutical industry is scaling up for the future

Learn more about our MRO and BOM tail solutions for pharmaceutical production lines.